Literature DB >> 27835031

Cardiogenic shock in pregnancy: Analysis from the National Inpatient Sample.

Jennifer Banayan1, Sarosh Rana2, Ariel Mueller3, Avery Tung1, Hadi Ramadan2, Zoltan Arany4, Junaid Nizamuddin1, Victor Novack3,5, Barbara Scavone1, Samuel M Brown6, Sajid Shahul1.   

Abstract

OBJECTIVE: Cardiogenic shock (CS) may occur during pregnancy and dramatically worsen peripartum outcomes.
METHODS: We analyzed the National Inpatient Sample from 2002 to 2013 to describe the incidence of, risk factors for and outcomes of CS during pregnancy.
RESULTS: Of the 53,794,192 hospitalizations analyzed, 2044 were complicated by CS. The mortality rate in peripartum women with CS was 18.81% versus 0.02% without. It occurs more often during postpartum (58.83%) as compared with delivery (23.47%) or antepartum (17.70%) hospitalizations. Factors associated with CS -related death included cardiac arrest, renal failure, and sepsis.
CONCLUSIONS: CS during pregnancy occurs more commonly in the postpartum period and is associated with a high mortality.

Entities:  

Keywords:  Cardiogenic shock; extracorporeal membrane oxygenation; incidence; maternal mortality; pregnancy

Mesh:

Year:  2016        PMID: 27835031     DOI: 10.1080/10641955.2016.1242606

Source DB:  PubMed          Journal:  Hypertens Pregnancy        ISSN: 1064-1955            Impact factor:   2.108


  3 in total

Review 1.  Animal Models of Cardiovascular Complications of Pregnancy.

Authors:  Zolt Arany; Denise Hilfiker-Kleiner; S Ananth Karumanchi
Journal:  Circ Res       Date:  2022-06-09       Impact factor: 23.213

Review 2.  Acute Coronary Syndrome in Pregnancy and the Post-Partum Period.

Authors:  Anna C O'Kelly; Jonathan Ludmir; Malissa J Wood
Journal:  J Cardiovasc Dev Dis       Date:  2022-06-23

Review 3.  Cardiovascular Complications of Pregnancy-Associated COVID-19 Infections.

Authors:  Joan E Briller; Niti R Aggarwal; Melinda B Davis; Afshan B Hameed; Isabelle Malhamé; Zainab Mahmoud; Emily G McDonald; Glaucia Moraes de Oliveira; Odayme Quesada; Nandita S Scott; Jyoti Sharma
Journal:  JACC Adv       Date:  2022-08-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.